Neal R. Barshes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Neal R. Barshes has a total of 162 co-authors. Here are the top co-authors by number of shared publications:
Panos Kougias
Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery Baylor College of Medicine
19 shared publicationsGeorge Pisimisis
Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Baylor College of Medicine/Michael E. DeBakey Veterans Affairs Medical Center, Houston, Tex
11 shared publications- Panos Kougias
Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Baylor College of Medicine / Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas 77030
11 shared publications - Michael Belkin
Division of Vascular Surgery, Brigham and Women's Hospital, Boston, Mass
8 shared publications Joseph L. Mills
6 shared publicationsNader Zamani
Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Baylor College of Medicine/Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas
6 shared publications
Latest Publications
- Open Access
Screening and Treatment of Carotid Stenosis in Patients with HPV-Associated Oropharyngeal Cancer
Patients with history of neck radiation for Human Papilloma Virus (HPV)-associated head and neck cancer experience rapid progression of carotid artery stenosis. The present study sought to determine whether screening and treating asymptomatic carotid artery stenosis in patients with a history of neck radiation is cost-effective. This study is a cost-utility analysis using a probabilistic Markov model over a thirty-year time horizon assessing carotid screening and treatment to avoid neurologic consequences of neck radiation for HPV-associated head and neck cancer. A strategy of no carotid surveillance was associated with a 14.8% cumulative risk of stroke and a strategy of ultrasound surveillance and treatment with TCAR was associated with a 3.0% cumulative risk of stroke. The latter had a median incremental cost of $1.04 million USD and provided a median 39.1 additional QALYs, resulting in a median incremental cost-effectiveness ratio of $26,556 per QALY. In conclusion, this study suggests that ultrasound surveillance and treatment with TCAR for asymptomatic carotid artery stenosis is likely to be cost-effective for patients who have been successfully treated with radiation therapy for HPV-associated head and neck cancer.
Open AccessScreening and Treatment of Carotid Stenosis in Patients with HPV-Associated Oropharyngeal Cancer
Patients with history of neck radiation for Human Papilloma Virus (HPV)-associated head and neck cancer experience rapid progression of carotid artery stenosis. The present study sought to determine whether screening and treating asymptomatic carotid artery stenosis in patients with a history of neck radiation is cost-effective. This study is a cost-utility analysis using a probabilistic Markov model over a thirty-year time horizon assessing carotid screening and treatment to avoid neurologic consequences of neck radiation for HPV-associated head and neck cancer. A strategy of no carotid surveillance was associated with a 14.8% cumulative risk of stroke and a strategy of ultrasound surveillance and treatment with TCAR was associated with a 3.0% cumulative risk of stroke. The latter had a median incremental cost of $1.04 million USD and provided a median 39.1 additional QALYs, resulting in a median incremental cost-effectiveness ratio of $26,556 per QALY. In conclusion, this study suggests that ultrasound surveillance and treatment with TCAR for asymptomatic carotid artery stenosis is likely to be cost-effective for patients who have been successfully treated with radiation therapy for HPV-associated head and neck cancer.
- Open Access
- 24 December 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (6) , 942-949
Baseline Haemodynamic Measurements and Immediate Change in Parameters after Revascularisation: Ankle Pressure, Ankle Brachial Index, Toe Pressure, and Toe Brachial Index Analysis of the BEST-CLI Participants
- 24 December 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (6) , 942-949
Open AccessBaseline Haemodynamic Measurements and Immediate Change in Parameters after Revascularisation: Ankle Pressure, Ankle Brachial Index, Toe Pressure, and Toe Brachial Index Analysis of the BEST-CLI Participants
- 27 October 2025
- Published by Springer Nature
- p. 311-327
Cost-Effectiveness of Claudication Treatment
- 9 October 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (3) , 699-709.e5
Cost-effectiveness analysis of surgical repair versus observation of complex abdominal aortic aneurysms in elderly patients
- 9 October 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (3) , 699-709.e5
Cost-effectiveness analysis of surgical repair versus observation of complex abdominal aortic aneurysms in elderly patients
- Open Access
Estimating the Rupture Risk of Large Abdominal Aortic Aneurysms
Objectives Determining the rupture risk of large abdominal aortic aneurysms (AAA) through clinical studies remains elusive. We sought to employ computational methods on existing literature data and briefly report on stratified rupture risk of large AAAs. Methods We reviewed published English-language literature reporting on rupture risk of large AAAs. Analysis of rupture risk was performed on Microsoft Excel and Visual Basic scripting. Outcome of interest was annual rupture probabilities stratified by aneurysm size (range 5.0/5.5 – 10.0 cm in women/men) and patient sex. Uncertainty in rupture probabilities was considered through probability distributions. Results For aneurysms sized 5.5 – 7.0 cm, estimated annual rupture probabilities in women were much higher than literature-reported estimates in men, ranging from 6.4% (95% confidence interval: 3.5% – 10.1%) to 54.5% (95% confidence interval: 39.3% – 69.3%). For aneurysms sized 7.5 cm, estimated annual rupture probabilities were 32.4% (95% confidence interval: 26.1% – 39.0%) in men and 64.8% (95% confidence interval: 51.3% – 77.1%) in women. For aneurysms sized 10.0 cm, estimated rupture probabilities increased to near-certainty at 96.6% (95% confidence interval: 94.0% – 98.5%) in men and 98.8% (95% confidence interval: 96.8% – 99.9%) in women. Conclusion Computational analysis of existing data is feasible to estimate stratified rupture probabilities of large AAAs, based on aneurysm size and patient sex. Further clinical studies are needed to obtain more precise estimates of rupture probabilities.
Open AccessEstimating the Rupture Risk of Large Abdominal Aortic Aneurysms
Objectives Determining the rupture risk of large abdominal aortic aneurysms (AAA) through clinical studies remains elusive. We sought to employ computational methods on existing literature data and briefly report on stratified rupture risk of large AAAs. Methods We reviewed published English-language literature reporting on rupture risk of large AAAs. Analysis of rupture risk was performed on Microsoft Excel and Visual Basic scripting. Outcome of interest was annual rupture probabilities stratified by aneurysm size (range 5.0/5.5 – 10.0 cm in women/men) and patient sex. Uncertainty in rupture probabilities was considered through probability distributions. Results For aneurysms sized 5.5 – 7.0 cm, estimated annual rupture probabilities in women were much higher than literature-reported estimates in men, ranging from 6.4% (95% confidence interval: 3.5% – 10.1%) to 54.5% (95% confidence interval: 39.3% – 69.3%). For aneurysms sized 7.5 cm, estimated annual rupture probabilities were 32.4% (95% confidence interval: 26.1% – 39.0%) in men and 64.8% (95% confidence interval: 51.3% – 77.1%) in women. For aneurysms sized 10.0 cm, estimated rupture probabilities increased to near-certainty at 96.6% (95% confidence interval: 94.0% – 98.5%) in men and 98.8% (95% confidence interval: 96.8% – 99.9%) in women. Conclusion Computational analysis of existing data is feasible to estimate stratified rupture probabilities of large AAAs, based on aneurysm size and patient sex. Further clinical studies are needed to obtain more precise estimates of rupture probabilities.
- 12 March 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 69 (3) , e245-e246
Advanced Wound, Ischemia, and foot Infection stage is associated with poor outcomes in the BEST-CLI trial
- 12 March 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 69 (3) , e245-e246
Advanced Wound, Ischemia, and foot Infection stage is associated with poor outcomes in the BEST-CLI trial
- 3 December 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 81 (3) , 720-729.e1
Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trial
- 3 December 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 81 (3) , 720-729.e1
Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trial
- 9 February 2023
- Published by SAGE Publications in Vascular Medicine
- Vol. 28 (1) , 45-53
Lower-extremity pressure, staging, and grading thresholds to identify chronic limb-threatening ischemia
Introduction: The Society for Vascular Surgery Threatened Limb Classification System (‘WIfI’) is used to predict risk of limb loss and identify peripheral artery disease in patients with foot ulcers or gangrene. We estimated the diagnostic sensitivity of multiple clinical and noninvasive arterial parameters to identify chronic limb-threatening ischemia (CLTI). Methods: We performed a single-center review of 100 consecutive patients who underwent angiography for foot gangrene or ulcers. WIfI stages and grades were determined for each patient. Toe, ankle, and brachial pressure measurements were performed by registered vascular technologists. CLTI severity was characterized using Global Limb Anatomic Staging System (GLASS stages) and angiosomes. Medial artery calcification in the foot was quantified on foot radiographs. Results: GLASS NA (not applicable), I, II, and III angiographic findings were seen in 21, 21, 23, and 35 patients, respectively. A toe–brachial index < 0.7 and minimum ipsilateral ankle–brachial index < 0.9 performed well in identifying GLASS II and III angiographic findings, with sensitivity rates 97.8% and 91.5%, respectively. The diagnostic accuracy rates of noninvasive measures peaked at 74.7% and 89.3% for identifying GLASS II/III and GLASS I+ angiographic findings, respectively. The presence of medial artery calcification significantly diminished the sensitivity of most noninvasive parameters. Conclusions: The use of alternative noninvasive arterial testing parameters improves sensitivity for detecting PAD. Abnormal noninvasive results should suggest the need for diagnostic angiography to further characterize arterial anatomy of the affected limb. Testing strategies with better accuracy are needed.
- 9 February 2023
- Published by SAGE Publications in Vascular Medicine
- Vol. 28 (1) , 45-53
Lower-extremity pressure, staging, and grading thresholds to identify chronic limb-threatening ischemia
Introduction: The Society for Vascular Surgery Threatened Limb Classification System (‘WIfI’) is used to predict risk of limb loss and identify peripheral artery disease in patients with foot ulcers or gangrene. We estimated the diagnostic sensitivity of multiple clinical and noninvasive arterial parameters to identify chronic limb-threatening ischemia (CLTI). Methods: We performed a single-center review of 100 consecutive patients who underwent angiography for foot gangrene or ulcers. WIfI stages and grades were determined for each patient. Toe, ankle, and brachial pressure measurements were performed by registered vascular technologists. CLTI severity was characterized using Global Limb Anatomic Staging System (GLASS stages) and angiosomes. Medial artery calcification in the foot was quantified on foot radiographs. Results: GLASS NA (not applicable), I, II, and III angiographic findings were seen in 21, 21, 23, and 35 patients, respectively. A toe–brachial index < 0.7 and minimum ipsilateral ankle–brachial index < 0.9 performed well in identifying GLASS II and III angiographic findings, with sensitivity rates 97.8% and 91.5%, respectively. The diagnostic accuracy rates of noninvasive measures peaked at 74.7% and 89.3% for identifying GLASS II/III and GLASS I+ angiographic findings, respectively. The presence of medial artery calcification significantly diminished the sensitivity of most noninvasive parameters. Conclusions: The use of alternative noninvasive arterial testing parameters improves sensitivity for detecting PAD. Abnormal noninvasive results should suggest the need for diagnostic angiography to further characterize arterial anatomy of the affected limb. Testing strategies with better accuracy are needed.
- Open Access
- 15 September 2022
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 9 (10) , ofac475
Polymicrobial Foot Infection Patterns Are Common and Associated With Treatment Failure
That foot infections are predominately polymicrobial has long been recognized, but it is not clear if the various species co-occur randomly or in patterns. We sought non-random species co-occurrence patterns that might help better predict prognosis or guide antimicrobial selection. We analyzed tissue (bone, skin, and other soft tissue), fluid and swab specimens collected from initial foot infection episodes during a 10-year period using a hospital registry. Non-random co-occurrence of microbial species was identified using simple pairwise co-occurrence rates adjusted for multiple comparisons, Markov and conditional random fields, and factor analysis. An historical cohort was used to validate pattern occurrence and identify clinical significance. In total 156 unique species identified among the 727 specimens obtained from initial foot infection episodes in 694 patients. Multiple analyses suggested Staphylococcus aureus is negatively associated with other staphylococci. Another pattern noted was the co-occurrence of alpha-hemolytic Streptococcus, Enterococcus fecalis, Klebsiella, Proteus, Enterobacter, or Escherichia coli and absence of both Bacteroides and Corynebacterium. Patients in an historical cohort with this latter pattern had significantly higher risk-adjusted rates of treatment failure. Several non-random microbial co-occurrence patterns are frequently seen in foot infection specimens. One particular pattern with many Proteobacteria species may denote a higher risk for treatment failure. Staphylococcus aureus rarely co-occurs with other staphylococci.
- 15 September 2022
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 9 (10) , ofac475
Open AccessPolymicrobial Foot Infection Patterns Are Common and Associated With Treatment Failure
That foot infections are predominately polymicrobial has long been recognized, but it is not clear if the various species co-occur randomly or in patterns. We sought non-random species co-occurrence patterns that might help better predict prognosis or guide antimicrobial selection. We analyzed tissue (bone, skin, and other soft tissue), fluid and swab specimens collected from initial foot infection episodes during a 10-year period using a hospital registry. Non-random co-occurrence of microbial species was identified using simple pairwise co-occurrence rates adjusted for multiple comparisons, Markov and conditional random fields, and factor analysis. An historical cohort was used to validate pattern occurrence and identify clinical significance. In total 156 unique species identified among the 727 specimens obtained from initial foot infection episodes in 694 patients. Multiple analyses suggested Staphylococcus aureus is negatively associated with other staphylococci. Another pattern noted was the co-occurrence of alpha-hemolytic Streptococcus, Enterococcus fecalis, Klebsiella, Proteus, Enterobacter, or Escherichia coli and absence of both Bacteroides and Corynebacterium. Patients in an historical cohort with this latter pattern had significantly higher risk-adjusted rates of treatment failure. Several non-random microbial co-occurrence patterns are frequently seen in foot infection specimens. One particular pattern with many Proteobacteria species may denote a higher risk for treatment failure. Staphylococcus aureus rarely co-occurs with other staphylococci.